Effect of culture media on lymphokine-activated killer effector phenotype and lytic capacity
- 1 March 1991
- journal article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 33 (2) , 103-108
- https://doi.org/10.1007/bf01742537
Abstract
We compared the ability of murine lymphokine-activated killer (LAK) cells grown in either a serum-supplemented “standard” medium (αMEM plus fetal calf serum) or a serum-free medium (AIM-V) to lyse a range of tumour targets. LAK cells grown in either of the media killed a cultured murine tumour line (YAC-1 lymphoma) well and spared syngeneic “self” cells (concanavalin-A-stimulated splenocytes). However, a striking difference was noted in the ability of LAK cells grown in αMEM plus fetal calf serum (as opposed to AIM-V) to kill “modified self” cells (trinitrophenol-modified concanavalin A blasts); LAK cells grown in the former always killed modified self cells better than those grown in the latter. This pattern held under a broad range of experimental manipulations and was found to be related to a relative increase in CD3-bearing LAK cells grown in the standard medium. These data suggest that the two media cannot be used interchangeably. This conclusion may have clinical implications for the use of LAK cells, as animal studies have been done using LAK cells generated in serum-containing medium and clinical studies have used LAK cells generated in serum-free medium.Keywords
This publication has 21 references indexed in Scilit:
- IL-2-based immunotherapy alters circulating neutrophil Fc receptor expression and chemotaxis.The Journal of Immunology, 1990
- Activation of the complement system during immunotherapy with recombinant IL-2. Relation to the development of side effects.The Journal of Immunology, 1990
- Lymphokine-activated killer (LAK) cells. IV. Characterization of murine LAK effector subpopulations.The Journal of Immunology, 1990
- Immunotherapy of cancer using interleukin 2: current status and future prospectsImmunology Today, 1988
- Development of New Immunologic Approaches to Cancer TherapyBlood Purification, 1988
- Studies of serum-free culture medium in the generation of lymphokine activated killer cellsJournal of Immunological Methods, 1987
- Lymphokine-activated killer (LAK) cells. II. Delineation of distinct murine LAK-precursor subpopulations.The Journal of Immunology, 1987
- Induction of lymphokine activated killer cells in serum-free mediumJournal of Immunological Methods, 1986
- The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo.The Journal of Immunology, 1985
- LYMPHOKINE-ACTIVATED KILLER CELLS - LYSIS OF FRESH SYNGENEIC NATURAL KILLER-RESISTANT MURINE TUMOR-CELLS BY LYMPHOCYTES CULTURED IN INTERLEUKIN-21984